Growth Metrics

Avanos Medical (AVNS) Cash from Operations (2016 - 2026)

Avanos Medical's Cash from Operations history spans 13 years, with the latest figure at 28200000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 51.3% to 28200000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 74700000.0, a 25.82% decrease, with the full-year FY2025 number at 74700000.0, down 25.82% from a year prior.
  • Cash from Operations hit 28200000.0 in Q4 2025 for Avanos Medical, up from 14000000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AVNS hit a ceiling of 57900000.0 in Q4 2024 and a floor of 8000000.0 in Q1 2024.
  • Historically, Cash from Operations has averaged 19300000.0 across 5 years, with a median of 23100000.0 in 2021.
  • Biggest five-year swings in Cash from Operations: soared 4636.36% in 2021 and later plummeted 477.78% in 2023.
  • Tracing AVNS's Cash from Operations over 5 years: stood at 52100000.0 in 2021, then tumbled by 35.32% to 33700000.0 in 2022, then crashed by 62.31% to 12700000.0 in 2023, then soared by 355.91% to 57900000.0 in 2024, then plummeted by 51.3% to 28200000.0 in 2025.
  • Business Quant data shows Cash from Operations for AVNS at 28200000.0 in Q4 2025, 14000000.0 in Q3 2025, and 6800000.0 in Q2 2025.